title: Capecitabine in advanced hepatocellular carcinoma.
authors.affiliation: Department of Surgery, Oncology and Gastroenterology, University Policlinic, University of Padua, Padua, Italy.
authors.forename: Francesca
authors.initials: F
authors.lastname: Murer
authors.affiliation: Department of Surgery, Oncology and Gastroenterology, University Policlinic, University of Padua, Padua, Italy.
authors.forename: Caterina
authors.initials: C
authors.lastname: Pozzan
authors.affiliation: Department of Surgery, Oncology and Gastroenterology, University Policlinic, University of Padua, Padua, Italy.
authors.forename: Giulia
authors.initials: G
authors.lastname: Peserico
authors.affiliation: Department of Surgery, Oncology and Gastroenterology, University Policlinic, University of Padua, Padua, Italy. Electronic address: fabio.farinati@unipd.it.
authors.forename: Fabio
authors.initials: F
authors.lastname: Farinati
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage* / Q000009:adverse effects; D000069287:Capecitabine / Q000008:administration & dosage* / Q000009:adverse effects; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009536:Niacinamide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010671:Phenylurea Compounds / Q000627:therapeutic use*; D000077157:Sorafenib; D016019:Survival Analysis
chemical_list: D000964:Antimetabolites, Antineoplastic; D010671:Phenylurea Compounds; D009536:Niacinamide; D000069287:Capecitabine; D000077157:Sorafenib